Spinocerebellar Ataxia Type 3

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS withdrawal · 2012-08-17
Clinical Trial Update: Pilot Study of Safety and Efficacy of Sodium Phenylbutyrate in Spinocerebellar Ataxia Type 3 [Phase 2]
Phase 2 pilot trial of sodium phenylbutyrate for Spinocerebellar Ataxia Type 3 has been withdrawn.